HI
MRNA icon

Horizon Investments’s Moderna MRNA Stock Holding History

Horizon Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$309K Buy
6,074
+361
+6% +$16.8K ﹤0.01% 919
2025
Q4 		$168K Buy
5,713
+107
+2% +$2.91K ﹤0.01% 989
2025
Q3 		$145K Sell
5,606
-145
-3% -$4.04K ﹤0.01% 948
2025
Q2 		$159K Buy
5,751
+754
+15% +$19.9K ﹤0.01% 909
2025
Q1 		$142K Buy
4,997
+319
+7% +$11.3K ﹤0.01% 588
2024
Q4 		$195K Buy
4,678
+82
+2% +$3.92K 0.01% 549
2024
Q3 		$307K Sell
4,596
-465
-9% -$42.7K 0.01% 449
2024
Q2 		$601K Buy
5,061
+513
+11% +$64.9K 0.02% 337
2024
Q1 		$485K Buy
4,548
+3
+0.1% +$302 0.01% 368
2023
Q4 		$452K Buy
4,545
+2,113
+87% +$178K 0.01% 359
2023
Q3 		$251K Buy
2,432
+67
+3% +$7.47K 0.01% 453
2023
Q2 		$287K Sell
2,365
-330
-12% -$44K 0.01% 427
2023
Q1 		$414K Sell
2,695
-3,470
-56% -$572K 0.01% 326
2022
Q4 		$1.11M Buy
6,165
+3,637
+144% +$595K 0.03% 202
2022
Q3 		$299K Sell
2,528
-1,428
-36% -$217K 0.01% 409
2022
Q2 		$565K Sell
3,956
-3,625
-48% -$518K 0.02% 259
2022
Q1 		$1.31M Buy
7,581
+37
+0.5% +$6.23K 0.04% 190
2021
Q4 		$1.92M Buy
7,544
+1,992
+36% +$582K 0.06% 150
2021
Q3 		$2.14M Buy
+5,552
New +$2.05M 0.06% 144

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Horizon Investments's MRNA Position: Q1 2026 in Review

Horizon Investments increased its Moderna (MRNA) stake by 6.3% in Q1 2026, buying an estimated $16.8K and bringing the position to 6,074 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #919.

Horizon Investments first reported a position in MRNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.14M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Horizon Investments held 6,074 shares of Moderna worth $309K as of Q1 2026.
  • Horizon Investments bought 361 Moderna shares in Q1 2026, an estimated $16.8K.
  • Moderna made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #919 holding.
  • Horizon Investments first reported a position in Moderna in Q3 2021 and has held it in 19 quarters since.
  • Horizon Investments's Moderna position peaked at $2.14M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.